varnotech
Beijing
About varnotech
Varnotech specializes in developing vaccines, antibodies, and adjuvants to combat diseases and viruses. It was founded in 2019.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $102.9M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2024)
- Website: varnotech.com.cnpublichtmlindex.html
Industries & Categories
Intellectual Property, Medical, Product Research
Canonical: https://fsome.com/organization/varnotech-72404 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.